undamentalytics Newsletter
Sign in

Astrana Health, Inc. cash flow statement

In fiscal 2025, Astrana Health, Inc.'s operations generated $115m of cash; it spent $10.1m on capital projects, leaving free cash flow of $104m. It returned $7.9m in dividends and $25.6m through buybacks.

Cash flow statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2011Jan 20112012Jan 20122013Jan 20132014Jan 20142015Mar 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Cash from operations−0−00−1−0225225144670826852115108
Depreciation and amortisation000001819191818181818284663
Stock-based pay002012312371622353941
Capital spending000003211119232981013
Free cash flow−0−00−2−019502413455159404410494
Free cash flow after stock pay−0−1−2−2−21747231142444318106654
Dividends paid—————2710186251311462482
Share buybacks———0013581691012618
Shares issued———101120004000———

Free cash flow is cash from operations minus capital spending. Free cash flow after stock pay also subtracts stock-based compensation, a real cost to shareholders that the cash flow statement adds back. Dividends, buybacks and shares issued are cash amounts for the period.

Compare with peers

Head to head: AMN vs ASTHASTH vs CHEASTH vs AVAHASTH vs OPCH

More: Health Care Services stocks compared, Health Care sector, rankings of US companies

Figures from Astrana Health, Inc.'s SEC filings (10-K and 10-Q), retrieved October 26, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Astrana Health, Inc.